cinobufotalin has been researched along with Carcinogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, G; Li, J; Li, X; Liu, J; Meng, H; Shen, M; Zhang, R; Zhao, L | 1 |
1 other study(ies) available for cinobufotalin and Carcinogenesis
| Article | Year |
|---|---|
Novel SREBP1 inhibitor cinobufotalin suppresses proliferation of hepatocellular carcinoma by targeting lipogenesis.
Topics: Animals; Apoptosis; Bufanolides; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Lipogenesis; Liver Neoplasms; Male; Mice; Molecular Docking Simulation; Sterol Regulatory Element Binding Protein 1; Xenograft Model Antitumor Assays | 2021 |